| 000 | 01660 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514190619.0 | ||
| 264 | 0 | _c20040714 | |
| 008 | 200407s 0 0 eng d | ||
| 022 | _a0003-2999 | ||
| 024 | 7 |
_a10.1213/01.ANE.0000114551.64123.79 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Vroege, R | |
| 245 | 0 | 0 |
_aThe impact of heparin-coated cardiopulmonary bypass circuits on pulmonary function and the release of inflammatory mediators. _h[electronic resource] |
| 260 |
_bAnesthesia and analgesia _cJun 2004 |
||
| 300 |
_a1586-1594 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCardiopulmonary Bypass _xinstrumentation |
| 650 | 0 | 4 |
_aCoated Materials, Biocompatible _xpharmacology |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeparin _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlatelet Count _xmethods |
| 650 | 0 | 4 |
_aRespiratory Function Tests _xmethods |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 700 | 1 | _avan Oeveren, W | |
| 700 | 1 | _avan Klarenbosch, J | |
| 700 | 1 | _aStooker, W | |
| 700 | 1 | _aHuybregts, M A J M | |
| 700 | 1 | _aHack, C E | |
| 700 | 1 | _avan Barneveld, L | |
| 700 | 1 | _aEijsman, L | |
| 700 | 1 | _aWildevuur, C R H | |
| 773 | 0 |
_tAnesthesia and analgesia _gvol. 98 _gno. 6 _gp. 1586-1594 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1213/01.ANE.0000114551.64123.79 _zAvailable from publisher's website |
| 999 |
_c14863889 _d14863889 |
||